Amarin Shares Skyrocket On Positive Cardio Trial Results
Amarin Corporation plc (NASDAQ: AMRN) stock more than tripled Monday after its latest study results showed the company’s fish oil capsules significantly reduce the risk of cardiovascular events. read more.....»»
BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment
Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»
Why MyoKardia’s Late-Stage Hypertophric Cardiomyopathy Study Is a Big Hit
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten......»»
Brickell Biotech"s stock rockets on positive trial results for excessive sweating treatment
Shares of Brickell Biotech Inc. were vaulted 61% higher on very heavy volume, putting them on track for the biggest one-day gain since the biopharmaceutical company went public 27 years ago, after.....»»
Applied Genetic Technologies" stock rockets on early-stage eye therapy data
Shares of Applied Genetic Technologies Corp. soared 60% on heavy volume in premarket trading on Thursday after the biotechnology company reported positive results from a Phase 1/2 trial for its investigational gene therapy for retinitis pigmentosa, a dis.....»»
Precision BioSciences stock rises on early-stage CAR-T trial data
Shares of Precision BioSciences Inc. are up 13% in premarket trading after it announced positive results from a small Phase 1 clinical trial for its chimeric antigen receptor (CAR) T cell therapy.....»»
Why Investors Shouldn’t Sleep on This Narcolepsy Study
Axsome Therapeutics shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial......»»
Brainsway shares up on smoking cessation data
Shares of Brainsway are up 10% in premarket trading on positive trial results for its brain stimulation device as a smoking cessation tool.....»»
AstraZeneca"s Triple Combo Lung Cancer Therapy Aces Late-Stage Trial
AstraZeneca plc (NYSE: AZN) shares were advancing Monday following a clinical readout from the company. What Happened The U.K.-based pharma giant said its Phase 3 POSEIDON trial produced positive results. read more.....»»
Bristol-Myers shares surge almost 5% premarket after positive results in lung-cancer trial
Bristol-Myers Squibb Co. shares rose almost 5% in premarket Tuesday, after the company reported positive result.....»»
Big Step Forward in HER2-Positive Breast Cancer Trial
Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial......»»
Seattle Genetics Rallies To Record High On Positive Results From Midstage Breast Cancer Study
Shares of the large-cap biopharma Seattle Genetics, Inc. (NASDAQ: SGEN) were advancing strongly Monday following a clinical trial readout from the company. read more.....»»
Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment
Opko Health Inc. shares soared 21% in premarket trade Monday, while Pfizer Inc. shares rose 0.6%, after the companies anno.....»»
Incyte reports positive results in late-stage trial of treatment for GVHD
Incyte Corp. shares rose 1.2% in premarket trade Wednesday, after the biotech said a.....»»
Why This Neuromuscular Disorder Study Could Be the Next Big Thing
Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial......»»
Pfizer shares up 1.3% premarket after reporting positive results in second trial of dermatitis treatment
Pfizer Inc. .....»»
Is This Epilepsy Cannabinoid Treatment Really in Trouble?
Zynerba Pharmaceuticals has announced positive results from its midstage epilepsy trial, and yet its shares dropped on Wednesday......»»
Is Amarin’s Cardio Trial in Trouble?
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application......»»
Capicor Therapeutics" stock rockets on heavy volume after positive MD trial results
Shares of Capricor Therapeutics Inc. nearly doubled (up 93%) in very active premarket trading Monday, after the biotechnology company announced upbeat results from a trial for its treatment (CAP-1002) of Duc.....»»
Bicycle Therapeutics Trades Higher On Positive Early-Stage Trial Results For Diabetic Macular Edema Therapy
Shares of Bicycle Therapeutics PLC (NASDAQ: BCYC), which debuted on Wall Street in May, traded higher on Monday morning. read more.....»»